Ida Gjervold Lunde

Researcher

Christensen group

Email: i.g.lunde@medisin.uio.no
Phone: +47 905 11 364

Ida Gjervold Lunde was PhD student, postdoctoral fellow and group leader at IEMR between 2008-2022, and continues her collaboration with IEMR researchers from Akershus University Hospital (Ahus) and University of Oslo (UoO).

Molecular biologist, MSc PhD FESC.

Funded by the Young Research Talent Program of the Research Council of Norway (RCN; 2017 – ).

Awarded several international and national awards, incl. Young Investigator Award (YIA) at the European Society of Cardiology (ESC; 2010, 2012, 2013) and His Majesty the King of Norway’s Gold Medal for Young Researchers (2012).

Selected/elected member of several research committees, incl. the Committee on Translational Research of the Heart Failure Ass (HFA) of the ESC (2014-2018), leader group of the Norwegian PhD School of Heart Research (NORHEART, 2013 – ), the Cardiovascular Board of Nasjonalforeningen for Folkehelsen (2018 – ) and Nucleus member of the Working Group of Myocardial Function of the ESC (2020 – ).

Research area

Cardiomyocyte signaling
Fibroblast signaling
Fibrosis
Genetic cardiology
Heart failure

Latest publications

view all >

Andreassen K, Dejgaard LA, Lie Ø, Fink TS, Lunde IG, Edvardsen T, Haugaa KH, Stokke MK (2022)
Exercise training during childhood and adolescence is associated with favorable diastolic function in hypertrophic cardiomyopathy
Int J Cardiol, 364, 65-71
PubMed 35714718 DOI 10.1016/j.ijcard.2022.06.042

Romaine A, Melleby AO, Alam J, Lobert VH, Lu N, Lockwood FE, Hasic A, Lunde IG, Sjaastad I, Stenmark H, Herum KM, Gullberg D, Christensen G (2022)
Integrin α11β1 and syndecan-4 dual receptor ablation attenuate cardiac hypertrophy in the pressure overloaded heart
Am J Physiol Heart Circ Physiol, 322 (6), H1057-H1071
PubMed 35522553 DOI 10.1152/ajpheart.00635.2021

Coats AJS, Heymans S, Farmakis D, Anker SD, Backs J, Bauersachs J, de Boer RA, Čelutkienė J, Cleland JGF, Dobrev D, van Gelder IC, von Haehling S, Hindricks G, Jankowska E, Kotecha D, van Laake LW, Lainscak M, Lund LH, Lunde IG, Lyon AR, Manouras A, Miličić D, Mueller C, Polovina M, Ponikowski P, Rosano G, Seferović PM, Tschöpe C, Wachter R, Ruschitzka F (2021)
Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology
Eur Heart J
PubMed 34875053 DOI 10.1093/eurheartj/ehab834

Rypdal KB, Erusappan PM, Melleby AO, Seifert DE, Palmero S, Strand ME, Tønnessen T, Dahl CP, Almaas V, Hubmacher D, Apte SS, Christensen G, Lunde IG (2021)
The extracellular matrix glycoprotein ADAMTSL2 is increased in heart failure and inhibits TGFβ signalling in cardiac fibroblasts
Sci Rep, 11 (1), 19757
PubMed 34611183 DOI 10.1038/s41598-021-99032-2

Frisk M, Le C, Shen X, Røe ÅT, Hou Y, Manfra O, Silva GJJ, van Hout I, Norden ES, Aronsen JM, Laasmaa M, Espe EKS, Zouein FA, Lambert RR, Dahl CP, Sjaastad I, Lunde IG, Coffey S, Cataliotti A, Gullestad L, Tønnessen T, Jones PP, Altara R, Louch WE (2021)
Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction
J Am Coll Cardiol, 77 (4), 405-419
PubMed 33509397 DOI 10.1016/j.jacc.2020.11.044

view all >